Clear Search sequence regions


  • adult (1)
  • and disease (1)
  • cicatrix (1)
  • female (1)
  • humans (1)
  • measures (1)
  • pathology (1)
  • patients (6)
  • phase (1)
  • scale (1)
  • speech (3)
  • steroids (2)
  • time factors (1)
  • vocal fold (8)
  • young adult (1)
  • Sizes of these terms reflect their relevance to your search.

    To assess the duration of clinical response after in-office vocal fold steroid injection (VFSI) for vocal fold (VF) scar. Demographic and clinical data for in-office VFSI occurring from 2017 to 2020 were collected. Two Speech-Language Pathologists (SLPs) used perceptual evaluation of voice and functional scales to evaluate blinded voice and laryngovideostroboscopy (LVS) samples collected pre- and post-injection across multiple timepoints. Blinded SLP ratings were used for 30 individual VFs undergoing initial injection in 18 patients. Persistent improvement in voice past 6 months was seen in 57% of patients after VFSI. Multiple measures of voice and amplitude, percent vibrating tissue, and closed phase predominance significantly improved at various follow-up timepoints on average. Accounting for patient heterogeneity and disease progression, in-office VFSI for VF scar is associated with sustained improvement in a subset of patients. Approximately half of patients can expect to experience a lasting improvement in voice. Future studies of larger scale are required to identify patient factors associated with long-term benefit. 4 Laryngoscope, 133:2333-2339, 2023. © 2023 The American Laryngological, Rhinological and Otological Society, Inc.

    Citation

    Lucas G Axiotakis, Necati Enver, Evan L Kennedy, Kimberly A Duncan, Michael J Pitman. Duration of Clinical Response After In-Office Steroid Injection for Vocal Fold Scar. The Laryngoscope. 2023 Sep;133(9):2333-2339

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36594519

    View Full Text